OncoRev study: effect of a multi-disciplinary rehabilitation program for cancer patients on quality of life - a randomised controlled multicentre trial

Dutch Cancer Society and Maastricht University (The Netherlands)0 个研究点目标入组 225 人开始时间: 2005年12月20日最近更新: 2015年1月13日

适应症

试验速览

暂无简介。

•1. Aged over 18 years
•2. Diagnosis of cancer (all types included)
•3. Last treatment minimally two month
•4. Life expectation of minimally one year
•5. Minimum of three answer ?yes? to the following questions:
•5.1. Physical complaints like aching muscles, problems with coordination, headache, nausea, heart palpitations, shortness of breath
•5.2. Reduced physical capacity as compared to before the illness, e.g. less able to walk, cycle or walk
•5.3. Psychological problems like increased level of anxiety, depression, uncertainty, shortage of energy or nervousness
•5.4. Increased level of fatigue
•5.5. Sleep disturbances
•5.6. Problems of coping with reduced physical and psychosocial functioning due to cancer
•6. Knowledge of the Dutch language

•1. Category 3 or 4 of the scheme of Winningham (Winningham 1991)
•2. Inability of travelling independently to the rehabilitation centre
•3. Cognitive disorder that might impede the participation in the rehabilitation program (for example: subjects who are unable to be instructed, to think in three dimensions, to fill in questionnaires)
•4. Emotional instability that is expected to possibly impede the participation in the rehabilitation program (for example getting divorced at the moment, death of a loved one)
•5. Certain restricted risks due to the disease and/or serious co-morbidity (cardiovascular disease, history of lung pathology [chronic obstructive pulmonary disease], diabetes, rheumatoid arthritis
•6. History of and/or actual serious psycho-pathology, psychotic complaints or alcohol abuse
•7. Restricted side-effects of medication (e.g. psycho-pharmaca in high doses)
•8. Need for intensive medical treatment or rehabilitation
•9. Participation in any other clinical trial that measures quality of life or physical functions (exception: follow-up evaluation of clinical trials)

发起方

Dutch Cancer Society and Maastricht University (The Netherlands)